Steps to construct educational interventions on sexual dysfunction for healthcare professionals and patients. Experiences from the SECRET research study-group

Autor: Rikke Meyer, Sita R. Kotnis, Cecilie M.Ø. Fog-Petersen, Lise Tarnow, Annamaria Giraldi, Gesche Jürgens, Charlotte B. Jacobsen

Publikováno v: PEC Innovation, Vol 5, Iss , Pp 100310- (2024)

Objectives: To design an educational intervention on sexual dysfunction for patients suffering from schizophrenia and diabetes based on patients' and other relevant stakeholders' preferences, and to offer transparency into the basic decision-making p

Externí odkaz: https://doaj.org/article/b811e3b4fd5e4c4cb1acae6f5daa12d5

Metformin may adversely affect orthostatic blood pressure recovery in patients with type 2 diabetes: substudy from the placebo-controlled Copenhagen Insulin and Metformin Therapy (CIMT) trial

Autor: Christian Stevns Hansen, Louise Lundby-Christiansen, Lise Tarnow, Christian Gluud, Christoffer Hedetoft, Birger Thorsteinsson, Bianca Hemmingsen, Niels Wiinberg, Simone B. Sneppen, Søren S. Lund, Thure Krarup, Sten Madsbad, Thomas Almdal, Bendix Carstensen, Marit E. Jørgensen, the CIMT study group

Publikováno v: Cardiovascular Diabetology, Vol 19, Iss 1, Pp 1-10 (2020)

Abstract Background Metformin has been shown to have both neuroprotective and neurodegenerative effects. The aim of this study was to investigate the effect of metformin in combination with insulin on cardiovascular autonomic neuropathy (CAN) and dis

Externí odkaz: https://doaj.org/article/6cde7852a4314b588757a999c744f536

Improving Diabetes Self-management by Providing Continuous Positive Airway Pressure Treatment to Patients With Obstructive Sleep Apnea and Type 2 Diabetes: Qualitative Exploratory Interview Study

Autor: Ditte Hjorth Laursen, Gitte Rom, Anne Margareta Banghøj, Lise Tarnow, Lone Schou

Publikováno v: JMIR Formative Research, Vol 5, Iss 7, p e27062 (2021)

BackgroundThere is a high prevalence of unexplained and unexplored obstructive sleep apnea (OSA) among patients with type 2 diabetes. The daytime symptoms of OSA include severe fatigue, cognitive problems, a decreased quality of life, and the reduced

Externí odkaz: https://doaj.org/article/9dd87dc76ce04c52a77a983ab940c971

Effect of 12‐week continuous positive airway pressure therapy on glucose levels assessed by continuous glucose monitoring in people with type 2 diabetes and obstructive sleep apnoea; a randomized controlled trial

Autor: Anne Margareta Banghøj, Christoffer Krogager, Peter Lommer Kristensen, Klavs Würgler Hansen, Esben Laugesen, Jesper Fleischer, Simon Lebech Cichosz, Per Løgstrup Poulsen, Martin Glymer Kirkegaard, Birger Thorsteinsson, Lise Tarnow

Publikováno v: Endocrinology, Diabetes & Metabolism, Vol 4, Iss 2, Pp n/a-n/a (2021)

Abstract Aim Obstructive sleep apnoea (OSA) is frequent in type 2 diabetes (T2D). The aim was to investigate the effect of a 12‐week treatment with continuous positive airway pressure (CPAP) on glycaemic control assessed by continuous glucose monit

Externí odkaz: https://doaj.org/article/a86a4e9c8e8941ffb0d3d70d0f2c4813

Continuous Glucose Monitoring-Recorded Hypoglycemia with Insulin Degludec or Insulin Glargine U100 in People with Type 1 Diabetes Prone to Nocturnal Severe Hypoglycemia

Autor: Julie Maria Bøggild Brøsen, Rikke Mette Agesen, Amra Ciric Alibegovic, Henrik Ullits Andersen, Henning Beck-Nielsen, Peter Gustenhoff, Troels Krarup Hansen, Christoffer Georg Riber Hedetoft, Tonny Joran Jensen, Charlotte Røn Stolberg, Claus Bogh Juhl, Susanne Søgaard Lerche, Kirsten Nørgaard, Hans-Henrik Parving, Lise Tarnow, Birger Thorsteinsson, Ulrik Pedersen-Bjergaard

Publikováno v: Brøsen, J M B, Agesen, R M, Alibegovic, A C, Andersen, H U, Beck-Nielsen, H, Gustenhoff, P, Hansen, T K, Hedetoft, C G R, Jensen, T J, Stolberg, C R, Juhl, C B, Lerche, S S, Nørgaard, K, Parving, H-H, Tarnow, L, Thorsteinsson, B & Pedersen-Bjergaard, U 2022, ' Continuous Glucose Monitoring-Recorded Hypoglycemia with Insulin Degludec or Insulin Glargine U100 in People with Type 1 Diabetes Prone to Nocturnal Severe Hypoglycemia ', Diabetes Technology & Therapeutics, vol. 24, no. 9, pp. 643-654 . https://doi.org/10.1089/dia.2021.0567
Brøsen, J M B, Agesen, R M, Alibegovic, A C, Ullits Andersen, H, Beck-Nielsen, H, Gustenhoff, P, Krarup Hansen, T, Hedetoft, C G R, Jensen, T J, Stolberg, C R, Bogh Juhl, C, Lerche, S S, Nørgaard, K, Parving, H H, Tarnow, L, Thorsteinsson, B & Pedersen-Bjergaard, U 2022, ' Continuous Glucose Monitoring-Recorded Hypoglycemia with Insulin Degludec or Insulin Glargine U100 in People with Type 1 Diabetes Prone to Nocturnal Severe Hypoglycemia ', Diabetes Technology & Therapeutics, vol. 24, no. 9, pp. 643-654 . https://doi.org/10.1089/dia.2021.0567

Background and Aims: Nocturnal hypoglycemia is mainly a consequence of inappropriate basal insulin therapy in type 1 diabetes (T1D) and may compromise optimal glycemic control. Insulin degludec is associated with a lower risk of nocturnal hypoglycemi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83477b07b58cfa9237757d8626ffbdc9
https://doi.org/10.1089/dia.2021.0567